pk 11195 has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 3 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Visigalli, I | 1 |
Moresco, RM | 1 |
Belloli, S | 1 |
Politi, LS | 1 |
Gritti, A | 1 |
Ungaro, D | 1 |
Matarrese, M | 1 |
Turolla, E | 1 |
Falini, A | 1 |
Scotti, G | 1 |
Naldini, L | 1 |
Fazio, F | 1 |
Biffi, A | 1 |
Chen, MK | 2 |
Baidoo, K | 1 |
Verina, T | 1 |
Guilarte, TR | 2 |
3 other studies available for pk 11195 and Clinically Isolated CNS Demyelinating Syndrome
Article | Year |
---|---|
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195.
Topics: Animals; Brain; Carbon Radioisotopes; Central Nervous System Diseases; Demyelinating Diseases; Disea | 2009 |
Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization.
Topics: Animals; Astrocytes; Autoradiography; Biomarkers; Cerebral Cortex; Cuprizone; Demyelinating Diseases | 2004 |
Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination.
Topics: Animals; Corpus Callosum; Cuprizone; Demyelinating Diseases; Isoquinolines; Male; Mice; Mice, Inbred | 2006 |